ABDULAZIZ AL GETHAMI | CARDIOLOGY | Excellence Award (Any Scientific field)

Dr. ABDULAZIZ AL GETHAMI | CARDIOLOGY | Excellence Award (Any Scientific field)

CONSULTATN, KING ABDULAZIZ CARDIAC CENTER, Saudi Arabia

Dr. Abdulaziz R. Algethami is an experienced interventional cardiologist and educator at King Abdulaziz Cardiac Center, Riyadh, Saudi Arabia. With expertise in structural heart disease interventions, including TAVI, Mitral Clip, and complex coronary interventions, he is also a program director for Adult Cardiology Fellowship Training. Dr. Algethami holds an MBA from Alfaisal University and has worked internationally, including at Dalhousie University, Canada, and San Raffaele University, Italy. His clinical interests extend to cardiology, critical care, and medical education. He is passionate about advancing cardiology through research and training the next generation of cardiologists.

Education

Dr. Abdulaziz R. Algethami has a robust educational background in medicine and business. He completed his MBA from Alfaisal University in 2023, enhancing his leadership skills in healthcare. He pursued advanced training in interventional cardiology at San Raffaele University, Italy (2019-2020), although his program was shortened due to the COVID-19 pandemic. He earned his MBBS from King Abdulaziz University, Jeddah, in 2009. His certifications include the American Board of Interventional Cardiology, Royal College of Physicians and Surgeons of Canada, and several other prominent qualifications in internal medicine and cardiology. His diverse academic background demonstrates his dedication to combining clinical excellence with effective leadership.

Experience

Dr. Abdulaziz R. Algethami has a distinguished career as an interventional cardiologist at King Abdulaziz Medical City, Riyadh, Saudi Arabia, since 2020. He has gained substantial expertise in complex cardiovascular procedures, including TAVI, Mitral Clip, and Impella insertion. Previously, he completed a fellowship in interventional cardiology at Dalhousie University, Canada, and has held multiple key academic and clinical positions. As a program director for the Adult Cardiology Fellowship Training at KSAU-HS, Dr. Algethami contributes to the development of future cardiologists. His clinical experience also extends to various leadership roles, such as serving as chief resident in cardiology at Dalhousie University and as an assistant professor at King Saud Bin Abdulaziz University. His career spans diverse roles in the healthcare industry, focusing on clinical excellence, education, and innovation.

Research Focus

Dr. Abdulaziz R. Algethami’s research interests primarily lie in structural heart disease interventions, including the use of TAVI, Mitral Clip, and coronary interventions for complex lesions. He has published on topics such as coronary access following TAVI, the long-term outcomes of TAVI in elderly patients, and the role of coronary lithotripsy in treating in-stent restenosis. He has contributed to multiple studies on cardiac function, including research into dilated cardiomyopathy in hyperthyroidism. Additionally, Dr. Algethami is passionate about exploring new treatments for calcified lesions and complex procedures in interventional cardiology. His work in these areas is guided by a commitment to improving patient outcomes and advancing medical knowledge.

Publication Top Notes

  • Intravascular ultrasound-guided coronary lithotripsy treatment of in-stent restenosis in saphenous venous graft 🫀💉
  • A QUALITY IMPROVEMENT INITIATIVE TO DECREASE THE INAPPROPRIATE USE OF TRANSTHORACIC ECHOCARDIOGRAMS IN HEART FAILURE OUTPATIENTS 📉❤️
  • Real-World Efficacy and Safety of Apixaban vs. Warfarin in Obese Atrial Fibrillation Patients: Propensity Matching Analysis 💊🧑‍⚕️
  • Dilated Cardiomyopathy in Hyperthyroidism can be Reversed with Treatment 🧠💔
  • CRT-700.57 The Need for Coronary Access 10 Years After Transcatheter Aortic Valve Implantation (TAVI) 💖🔬
  • TCT-478 Long-Term 10 Years’ Follow-Up for Valve Dysfunction and Mean Gradient Change in Transcatheter Aortic Valve Replacement (TAVR) 🏥🔎

 

 

 

Funda Başyiğit | Cardiology | Best Researcher Award

Assoc Prof Dr Funda Başyiğit | Cardiology | Best Researcher Award

Cardiology at Ankara Etlik City Hospital in Turkey

Dr. Fikret Başyiğit is an esteemed cardiologist with over 22 years of experience in diagnosing and treating cardiovascular conditions. He specializes in interventional cardiology with a proven track record of advanced interventional procedures. His expertise spans preventive cardiology, echocardiography, and invasive cardiology, offering comprehensive patient care. Currently an Associate Professor at Ankara Etlik City Hospital, he has held various consultant positions across prominent hospitals in Turkey. Dr. Başyiğit is also an active researcher and has published numerous influential papers on topics like myocardial infarction and coronary artery disease. He is dedicated to staying at the forefront of cardiology research and innovations, aiming to advance both clinical practices and patient outcomes.

Profile

Strengths for the Award

  • Extensive Experience: With over two decades of experience in cardiology, including expertise in preventive and invasive cardiology, the candidate has demonstrated a broad range of skills in the field.
  • High Publication Volume: The individual has co-authored numerous peer-reviewed articles in reputable journals, focusing on various aspects of cardiology such as myocardial infarction, coronary artery disease, and advanced cardiac imaging techniques.
  • Cutting-edge Research: Their work on serum pleiotrophin levels, thrombus burden, and the predictive value of novel scores for cardiac conditions showcases a commitment to advancing medical knowledge.
  • Collaborative Projects: The person has collaborated with a diverse group of specialists, which adds credibility to their ability to work within multidisciplinary teams—vital for research development.
  • Academic Leadership: The current role as an Associate Professor and experience in leading complex interventional procedures suggest both academic and practical expertise.

Areas for Improvement

  • Citations and Impact: Although there are citations associated with the individual’s work, increasing the impact factor of their research and gaining more citations could strengthen their case for awards.
  • Further Innovation: Expanding the scope of research beyond current themes to include more innovative or emerging topics within cardiology, such as AI integration or personalized medicine, could enhance the overall research impact.

Education 

Dr. Fikret Başyiğit earned his undergraduate degree in Medicine from Hacettepe University’s Faculty of Medicine (English) between September 1996 and June 2002. Following this, he pursued specialized postgraduate training at Yüksek İhtisas Training and Research Hospital, focusing on cardiology from October 2002 to March 2008. His in-depth education and training have equipped him with comprehensive knowledge in cardiovascular health, diagnostics, and therapeutic interventions. This robust academic foundation has paved the way for his clinical success and contributions to cardiology, especially in invasive cardiology and myocardial research. With ongoing dedication to learning and advancement, Dr. Başyiğit continually integrates the latest developments in the field into his practice, ensuring the highest standard of patient care and clinical outcomes.

Research Focus 

Dr. Fikret Başyiğit’s research is primarily centered on cardiovascular disease, myocardial infarction, and coronary artery disease. His work delves into the relationship between biomarkers like serum pleiotrophin levels and clinical outcomes in patients with non-ST-segment elevation myocardial infarction. Additionally, he explores advanced diagnostic tools like echocardiography and the predictive value of various scoring systems in determining thrombus burden. Another focus area is preventive cardiology, examining factors like neutrophil to HDL-C ratios and their association with coronary artery stenosis. Dr. Başyiğit has also contributed research on innovative imaging techniques for mitral annulus perforation and the effects of implantable cardioverter defibrillators. His research not only advances understanding but also informs better clinical strategies to improve cardiovascular health outcomes.

Publication

  • 📝 The Relationship Between SYNTAX II Score and Serum Pleiotrophin Level in Patients with Non-ST-Segment Elevation Myocardial Infarction (2023)
  • 📝 3-Dimensional Images of Mitral Annulus Perforation: An Alien’s Mouth (2022)
  • 📝 The Predictive Value of MAPH Score for Determining Thrombus Burden in Patients with Non-ST Segment Elevation Myocardial Infarction (2022)
  • 📝 Association of Serum Pleiotrophin Levels with Acute Coronary Syndrome (2022)
  • 📝 The Role of Serum Resolvin D1 Levels in Determining the Presence and Prognosis of ST-Segment Elevation Myocardial Infarction (2022)
  • 📝 Relationship Between the Neutrophil to HDL-C Ratio and Anatomical Significance of Coronary Artery Stenosis in Patients with Documented Myocardial Ischemia (2022)
  • 📝 Effect of Implantable Cardioverter Defibrillator Implantation on Frontal QRS-T Angle (2022)
  • 📝 Serum Thiol Levels and Thiol/Disulfide Homeostasis in Patients with Rheumatic Mitral Valve Disease and Healthy Subjects (2021)
  • 📝 Can Hemodialysis Change QRS Axis in Patients Without Cardiovascular Disease? (2018)
  • 📝 Combination of Change in Hematological Parameters with Exercise Stress Test to Predict Coronary Artery Disease (2018)

Conclusion

The individual is a highly qualified and experienced cardiologist with a rich research background, making them a strong candidate for the “Best Researcher Award.” While additional citations and innovation would further solidify their standing, the depth of their work in cardiovascular research, combined with their professional roles, firmly supports their suitability for this recognition.